Clinical trial
Efficacy and Safety of Duloxetine
NCT00190619 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00190619 |
|---|---|
| Title | Efficacy and Safety of Duloxetine |
| Official title | Efficacy and Safety of Duloxetine Compared With Placebo in Subjects Electing Surgery for Severe Pure Genuine Stress Incontinence |
| Lead sponsor | Eli Lilly and Company, Industry |
| Collaborators | Boehringer Ingelheim Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Urinary Stress Incontinence |
| Intervention type | Drug |
| Interventions | Duloxetine, Placebo |
| Enrollment | 100 |
| Start date | May 1, 2001 |
| Completion | May 1, 2006 |
| First posted | Sep 19, 2005 |
| Last update posted | Jan 26, 2007 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: